# Intravenous Vasodilator vs. Inotropic Therapy in Patients With Heart Failure

> **NCT02767024** · PHASE4 · WITHDRAWN · sponsor: **Montefiore Medical Center**

## Conditions studied

- Acute Heart Failure

## Interventions

- **DRUG:** Sodium nitroprusside
- **DRUG:** Dobutamine
- **DRUG:** Furosemide

## Key facts

- **NCT ID:** NCT02767024
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-05-01
- **Primary completion:** 2018-05-01
- **Final completion:** 2018-06-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No patients enrolled
- **Last updated:** 2018-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02767024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02767024, "Intravenous Vasodilator vs. Inotropic Therapy in Patients With Heart Failure". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT02767024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*